Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated HBV Vaccination Immunogenicity in Adults Before Living-Donor Kidney Transplantation
jRCTs041260011Recruiting
- Start
- May 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV). Primary endpoint: Seroconversion rate of anti-HBs prior to transplantation or rituximab administration. Started May 2026; status: recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on jRCTs041260011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041260011.